Global Market Share for Circulating Tumor Cells Will Cross US $30.78 Billion By 2029, at 14.9% CAGR

The global circulating tumor cells market size is expected to reach USD 30.78 Billion by 2029 according to a new study by Polaris Market Research.

Cancer cells that have split away from the main lump and appear in the circulatory system as single units or clusters are known as CTCs. The increasing prevalence of cancer disease, increasing R&D activities of therapies, and increased demand for personalized medicine are driving the circulating tumor cells market growth.

In 2021, the North American region accounted for the largest share in the global industry. The U.S is among the major countries across the world, which spends heavenly in the healthcare sector. Furthermore, with the rising cases of different types of cancer disease, the growing need for preventative medicine and companion diagnostics are driving the industry in the region.

(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, Table of Contents, Graphical introduction of regional analysis, Top players in the market with their revenue analysis and our research methodology.)

The devices segment holds the largest share in 2021. This is due to the large range of products available in this area, as well as upcoming advancements in microfluidics technology.

Request for Discount on this Report Before Purchase @ https://www.polarismarketresearch.com/industry-analysis/circulating-tumor-cells-market/request-for-discount-pricing

Key industry players are AVIVA Biosciences BIOCEPT, Inc., BioFluidica, BioCEP Ltd, Biolidics Limited, Canopus Bioscience Ltd., Creativ MicroTech, Inc., Bio-Techne Corporation, Epic Sciences, Greiner Bio-One International GmbH, Fluxion Biosciences, Inc., Ikonisys Inc, IVDiagnostics, LineaRx, Inc. (Vitatex, Inc.), Menarini Silicon Biosystems, Miltenyi Biotec, Precision for Medicine, LungLife AI, Inc., QIAGEN, ScreenCell, STEMCELL Technologies, Inc., Sysmex Corporation.

Browse detail report with in-depth TOC @ https://www.polarismarketresearch.com/industry-analysis/circulating-tumor-cells-market

Polaris Market Research has segmented the circulating tumor cells market report on the basis of technology, application, product, specimen, and region: 

Circulating Tumor Cells, Technology Outlook (Revenue – USD Million, 2017 – 2029)

  • Circulating Tumor Cells Detection & Enrichment Methods
    • Immunocapture
    • Size-based Separation
    • Density-based Separation
    • Combined Methods
  • Circulating Tumor Cells Direct Detection Methods
    • SERS
    • Microscopy
    • Others
  • Circulating Tumor Cells Analysis

Circulating Tumor Cells, Application Outlook (Revenue – USD Million, 2017 – 2029)

  • Clinical/Liquid Biopsy
  • Research

Circulating Tumor Cells, Product Outlook (Revenue – USD Million, 2017 – 2029)

  • Kits & Reagents
  • Blood Collection Tubes
  • Devices or Systems

Circulating Tumor Cells, Specimen Outlook (Revenue – USD Million, 2017 – 2029)

  • Blood
  • Bone Marrow
  • Other Body Fluids

About Us:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.